Label-Free Phosphoproteomic Approach for Kinase Signaling Analysis.

Phosphoproteomics is a powerful platform for the unbiased profiling of kinase-driven signaling pathways. Quantitation of phosphorylation can be performed by means of either labeling or label-free mass spectrometry (MS) methods. Because of their simplicity and universality, label-free methodology is gaining acceptance and popularity in molecular biology research. Analytical workflows for label-free quantification of phosphorylation, however, need to overcome several hurdles for the technique to be accurate and precise. These include the use of biochemical extraction procedures that efficiently and reproducibly isolate phosphopeptides from complex peptide matrices and an analytical strategy that can cope with missing MS/MS phosphopeptide spectra in a subset of the samples being compared. Testing the accuracy of the developed workflows is an essential prerequisite in the analysis of small molecules by MS, and this is achieved by constructing calibration curves to demonstrate linearity of quantification for each analyte. This level of analytical rigor is rarely shown in large-scale quantification of proteins using either label-based or label-free techniques. In this chapter we show an approach to test linearity of quantification of each phosphopeptide quantified by liquid chromatography (LC)-MS without the need to synthesize standards or label proteins. We further describe the appropriate sample handling techniques required for the reproducible recovery of phosphopeptides and explore the essential algorithmic features that enable the handling of missing MS/MS spectra and thus make label-free data suitable for such analyses. The combined technology described in this chapter expands the applicability of phosphoproteomics to questions not previously tractable with other methodologies.

[1]  Sean J Humphrey,et al.  High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics , 2015, Nature Biotechnology.

[2]  B. Vanhaesebroeck,et al.  Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance* , 2012, Molecular & Cellular Proteomics.

[3]  O. Jensen,et al.  Analytical strategies in mass spectrometry-based phosphoproteomics. , 2011, Methods in molecular biology.

[4]  S. Joel,et al.  Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells , 2013, Science Signaling.

[5]  Martin R Larsen,et al.  Titanium dioxide as chemo-affinity chromatographic sorbent of biomolecular compounds--applications in acidic modification-specific proteomics. , 2011, Journal of proteomics.

[6]  Pedro R Cutillas,et al.  A Self-validating Quantitative Mass Spectrometry Method for Assessing the Accuracy of High-content Phosphoproteomic Experiments* , 2010, Molecular & Cellular Proteomics.

[7]  R. Braithwaite,et al.  Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography-tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  B. Vanhaesebroeck,et al.  Quantitative Profile of Five Murine Core Proteomes Using Label-free Functional Proteomics*S , 2007, Molecular & Cellular Proteomics.

[9]  S. Gerber,et al.  Rapid and reproducible single-stage phosphopeptide enrichment of complex peptide mixtures: application to general and phosphotyrosine-specific phosphoproteomics experiments. , 2011, Analytical chemistry.

[10]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[11]  I. Vendrell,et al.  Cross-species Proteomics Reveals Specific Modulation of Signaling in Cancer and Stromal Cells by Phosphoinositide 3-kinase (PI3K) Inhibitors* , 2014, Molecular & Cellular Proteomics.

[12]  Patrick G. A. Pedrioli,et al.  Phosphoproteomic Analysis Reveals Interconnected System-Wide Responses to Perturbations of Kinases and Phosphatases in Yeast , 2010, Science Signaling.

[13]  Martin R Larsen,et al.  Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. , 2007, Rapid communications in mass spectrometry : RCM.

[14]  M. Mann,et al.  Quantitative Phosphoproteomics Applied to the Yeast Pheromone Signaling Pathway*S , 2005, Molecular & Cellular Proteomics.

[15]  Pedro R. Cutillas,et al.  Environmental Stress Affects the Activity of Metabolic and Growth Factor Signaling Networks and Induces Autophagy Markers in MCF7 Breast Cancer Cells* , 2014, Molecular & Cellular Proteomics.

[16]  M. Larsen,et al.  Analytical strategies for phosphoproteomics , 2009, Expert review of neurotherapeutics.

[17]  A. Heck,et al.  Single-step Enrichment by Ti4+-IMAC and Label-free Quantitation Enables In-depth Monitoring of Phosphorylation Dynamics with High Reproducibility and Temporal Resolution * , 2014, Molecular & Cellular Proteomics.

[18]  P. Cutillas,et al.  Characterization of a TiO2 enrichment method for label-free quantitative phosphoproteomics , 2011, Methods.

[19]  Rong Zeng,et al.  Effect of peptide-to-TiO2 beads ratio on phosphopeptide enrichment selectivity. , 2009, Journal of proteome research.

[20]  P. Cutillas,et al.  Global profiling of protein kinase activities in cancer cells by mass spectrometry. , 2012, Journal of proteomics.

[21]  Martin R Larsen,et al.  Multidimensional strategy for sensitive phosphoproteomics incorporating protein prefractionation combined with SIMAC, HILIC, and TiO(2) chromatography applied to proximal EGF signaling. , 2011, Journal of proteome research.

[22]  J. Shabanowitz,et al.  Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae , 2002, Nature Biotechnology.

[23]  Hans H Maurer,et al.  What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? , 2013, Journal of chromatography. A.

[24]  F. Iorio,et al.  Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors , 2013, Genome Biology.

[25]  J. Gribben,et al.  Empirical inference of circuitry and plasticity in a kinase signaling network , 2015, Proceedings of the National Academy of Sciences.